Pluripotent hematopoietic stem cells (HSCs) are a rare population of cells with the ability to differentiate into all blood cell lineages. They can be identified and characterized using specific antibody markers. Common markers for HSCs include CD34 and CD133, which are surface proteins expressed on these cells, allowing researchers to isolate and study them for their regenerative potential and therapeutic applications in hematological disorders.